Cerebral oxygen extraction fraction (OEF) is a potential biomarker in various diseases. The current gold standard to measure OEF is 15O-PET, but its clinical applications are impeded by inherent limitations. To facilitate broader clinical applications of OEF as a disease biomarker, in this work, we compared the whole-brain OEF measurement of a non-invasive MRI technique, T2-relaxation-under-spin-tagging (TRUST), with the gold standard PET measurement, and demonstrated a strong linear correlation and no systematic difference between the two methods.
This abstract and the presentation materials are available to members only; a login is required.